Matches in SemOpenAlex for { <https://semopenalex.org/work/W2399215434> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2399215434 endingPage "52" @default.
- W2399215434 startingPage "248" @default.
- W2399215434 abstract "Lipid peroxidation in the kidney has been shown to precede proteinuria in puromycin aminonucleoside (PAN)-induced nephropathy. The aim of this study was to determine if L-2-oxothiazolidine-4-carboxylic acid (procysteine) would protect rats against PAN-induced nephrotoxicity. Male Sprague-Dawley rats were treated with procysteine (16 mg/100 g body weight i.p.) 24 h and 30 min prior to receiving a single injection of PAN (15 mg/100 g body weight i.v.) followed by procysteine in the drinking water (4 g/l). Control rats received procysteine alone (intraperitoneally and in drinking water) or PAN alone and then plain water. Proteinuria was not significantly different between PAN/ procysteine and PAN groups, reaching a maximum at day 14 and persisting at day 28. Lipid peroxidation was more severe in PAN/procysteine rats reaching a maximum at day 3 (253 +/- 30 ng/mg protein) compared to day 5 in PAN rats (196 +/- 20 ng/mg protein). Procysteine alone did not modulate proteinuria over 28 days or lipid peroxidation over 7 days. GSH levels over 7 days were not elevated by procysteine and were virtually zero in PAN and PAN/procysteine rats. Focal glomerulosclerosis (FGS) was worse at day 28 in PAN/procysteine rats than in PAN rats (39 +/- 8.2 vs. 23 +/- 4.5%; p < 0.05). This study shows that procysteine as a potential source of reducing equivalents does not protect against renal lipid peroxidation and FGS in this model. On the contrary, PAN/procysteine rats developed significantly more FGS through yet unknown mechanisms." @default.
- W2399215434 created "2016-06-24" @default.
- W2399215434 creator A5025902088 @default.
- W2399215434 creator A5040709977 @default.
- W2399215434 creator A5066813798 @default.
- W2399215434 creator A5072202968 @default.
- W2399215434 creator A5076541550 @default.
- W2399215434 date "1996-07-01" @default.
- W2399215434 modified "2023-10-18" @default.
- W2399215434 title "Supplementation with L-2-oxothiazolidine-4-carboxylic acid, a cysteine precursor, does not protect against lipid peroxidation in puromycin aminonucleoside-induced nephropathy." @default.
- W2399215434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8864728" @default.
- W2399215434 hasPublicationYear "1996" @default.
- W2399215434 type Work @default.
- W2399215434 sameAs 2399215434 @default.
- W2399215434 citedByCount "2" @default.
- W2399215434 countsByYear W23992154342014 @default.
- W2399215434 countsByYear W23992154342018 @default.
- W2399215434 crossrefType "journal-article" @default.
- W2399215434 hasAuthorship W2399215434A5025902088 @default.
- W2399215434 hasAuthorship W2399215434A5040709977 @default.
- W2399215434 hasAuthorship W2399215434A5066813798 @default.
- W2399215434 hasAuthorship W2399215434A5072202968 @default.
- W2399215434 hasAuthorship W2399215434A5076541550 @default.
- W2399215434 hasConcept C126189478 @default.
- W2399215434 hasConcept C126322002 @default.
- W2399215434 hasConcept C134018914 @default.
- W2399215434 hasConcept C181199279 @default.
- W2399215434 hasConcept C185592680 @default.
- W2399215434 hasConcept C2776151105 @default.
- W2399215434 hasConcept C2777390665 @default.
- W2399215434 hasConcept C2779200571 @default.
- W2399215434 hasConcept C2779561371 @default.
- W2399215434 hasConcept C2780091579 @default.
- W2399215434 hasConcept C2780829032 @default.
- W2399215434 hasConcept C2781175652 @default.
- W2399215434 hasConcept C2781184683 @default.
- W2399215434 hasConcept C3675279 @default.
- W2399215434 hasConcept C538909803 @default.
- W2399215434 hasConcept C55493867 @default.
- W2399215434 hasConcept C555293320 @default.
- W2399215434 hasConcept C71924100 @default.
- W2399215434 hasConceptScore W2399215434C126189478 @default.
- W2399215434 hasConceptScore W2399215434C126322002 @default.
- W2399215434 hasConceptScore W2399215434C134018914 @default.
- W2399215434 hasConceptScore W2399215434C181199279 @default.
- W2399215434 hasConceptScore W2399215434C185592680 @default.
- W2399215434 hasConceptScore W2399215434C2776151105 @default.
- W2399215434 hasConceptScore W2399215434C2777390665 @default.
- W2399215434 hasConceptScore W2399215434C2779200571 @default.
- W2399215434 hasConceptScore W2399215434C2779561371 @default.
- W2399215434 hasConceptScore W2399215434C2780091579 @default.
- W2399215434 hasConceptScore W2399215434C2780829032 @default.
- W2399215434 hasConceptScore W2399215434C2781175652 @default.
- W2399215434 hasConceptScore W2399215434C2781184683 @default.
- W2399215434 hasConceptScore W2399215434C3675279 @default.
- W2399215434 hasConceptScore W2399215434C538909803 @default.
- W2399215434 hasConceptScore W2399215434C55493867 @default.
- W2399215434 hasConceptScore W2399215434C555293320 @default.
- W2399215434 hasConceptScore W2399215434C71924100 @default.
- W2399215434 hasIssue "4" @default.
- W2399215434 hasLocation W23992154341 @default.
- W2399215434 hasOpenAccess W2399215434 @default.
- W2399215434 hasPrimaryLocation W23992154341 @default.
- W2399215434 hasRelatedWork W118444721 @default.
- W2399215434 hasRelatedWork W1972112080 @default.
- W2399215434 hasRelatedWork W2021748170 @default.
- W2399215434 hasRelatedWork W2026328040 @default.
- W2399215434 hasRelatedWork W2059849167 @default.
- W2399215434 hasRelatedWork W2079805362 @default.
- W2399215434 hasRelatedWork W2091590355 @default.
- W2399215434 hasRelatedWork W2115042832 @default.
- W2399215434 hasRelatedWork W2331446649 @default.
- W2399215434 hasRelatedWork W2399215434 @default.
- W2399215434 hasVolume "4" @default.
- W2399215434 isParatext "false" @default.
- W2399215434 isRetracted "false" @default.
- W2399215434 magId "2399215434" @default.
- W2399215434 workType "article" @default.